Abstract and Introduction
Introduction
Although not approved by the Food and Drug Administration for use in children younger than 16 years of age, ketamine is among the most widely used agents for procedural sedation and analgesia in pediatrics.[1–3] Over the past decade, ketamine infusions have also become more widely used as an adjunct to traditional opioid and benzodiazepine regimens for long-term sedation and analgesia in children. With clinical studies in children dating from 1990, there is an extensive amount of literature describing its safety and efficacy in this population.[4,5]
Pediatr Pharm. 2016;22(6) © 2016 University of Virginia
